Harvard Innovation Labs Ventures in Biotech and Therapeutics

(This round-up is for informational purposes only and in alphabetical order)

1) Ilios Therapeutics: Led by Luca Giani and the team, Ilios Therapeutics is pioneering multi-functional small molecules to combat neurodegenerative diseases. Know More At: iliostx.com

2) InGel Therapeutics: Led by Pierre C Dromel, Ph.D., Deepti Singh, Ph.D, and Patrick Jiang, InGel Therapeutics is a regenerative cell-therapy biotech leveraging novel neuro-protective and neuro-repairing mechanisms to tackle retinal degeneration. Know More At: ingeltx.com

3) Kestrel Therapeutics: Led by Frank Haluska, MD, PHD and the team, Kestrel Therapeutics is discovering and developing new molecules to treat intractable cancers. Know More At: kestreltherapeutics.com

4) Kinnos: Kinnos is adding color to disinfectants, visualizing surface coverage for more effective and efficient cleaning in healthcare settings. Know More At: kinnos.com

5) KiraGen Bio: Led by Aaron Edwards, Ryan Murray, and the team, KirGen Bio is harnessing the power of AI-driven combinatorial gene editing to unlock the full potential of solid tumor CAR-T therapies. Know More At: kiragenbio.com

6) Lime Therapeutics: Led by Shardule Shah, PhD, MBA, Prakrit Jena, PhD, Daniel Heller, PhD, and the team, Lime Therapeutics is creating a new class of therapies targeting lipid metabolism in cancers and neurodegenerative disorders. Know More At: limetherapeutics.com

7) Linton Lifesciences: Led by Ricky Solorzano and the team, Linton Lifesciences is using 3D bioprinting to create custom arteries for bypass surgery, aiming to replace traditional autologous grafts. Know More At: linton.life

8) Lybra Bio: Led by Michael Schrader, Núria Puigmal, PhD, Natalie Artzi, PhD, Jamil R. Azzi, MD, PhD, and the team, Lybra Bio's mission is to go beyond symptom relief, addressing the root cause of immune dysregulation and transforming the standard of care for autoimmune skin diseases with precision-engineered therapeutics. Know More At: lybrabio.com

9) Manifold Bio: Led by Gleb Kuznetsov, PhD, Pierce Ogden, PhD, Shane Lofgren, George Church, PhD, and the team, Manifold Bio has built the first high-throughput in vivo (HTV) discovery engine, combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Know More At: manifold.bio